US 9,540,330 B2Granted

Oligomer-containing hydantoin compounds

AssigneeNektar Therapeutics

InventorsJennifer Riggs-Sauthier, Stephanie Allums-Donald

Life of this patent

Estimating the term…

Abstract

The invention relates to (among other things) oligomer-containing hydantoin compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.

Claims3

Dependent claims

A pharmaceutical composition comprising a compound of formula:

and pharmaceutically acceptable salts thereof, wherein:
n is 1 to 12;
and
the compound is present in a dosage form.

1 more element

Dependencies are inferred from the claim text.

Facts

Application: 13/994,606Filed 15 Dec 2011 · us provisional application
Priority: 15 Dec 2010
Published: US 2014/0039020 A16 Feb 2014
Granted: 10 Jan 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 233/72
With hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals,…:…
A61K 47/60
Obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes: the organic…
A61P 25/08
Drugs for disorders of the nervous system: antiepileptics; Anticonvulsants
C07D 233/80
Two oxygen atoms, e.g. hydantoin: with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Family

Application61/423,411Us provisional application · filed 15 Dec 2010
US 2014/0039020 A1Pre-grant publication · published 6 Feb 2014
US 9,540,330 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results